Severe Asthma

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link:

Contents of this Issue


Page 15 of 15

Disclaimer is Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. is Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. e ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aer consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. Source Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-73. e guidelines were a cooperative effort among the American oracic Society and the European Respiratory Society. 106 Commerce Street, Suite 105 Lake Mary, FL 32746 TEL: 407.878.7606 • FAX: 407.878.7611 Order additional copies at Copyright © 2015 All rights reserved ATSASTH15102c Abbreviations ABPA, allergic bronchopulmonary aspergillosis; ACQ, Asthma Control Questionnaire; ACT, Asthma Control Test; ATS, American oracic Society; CS, corticosteroids; DLCO, transfer factor of the lung for carbon monoxide; DPI, dry powder inhaler; FeNO, exhaled nitric oxide fraction; FEV1, forced expiratory volume in 1 second; GINA, Global Initiative for Asthma; HRCT, high-resolution computed tomography; ICS, inhaled corticosteroid; IL, interleukin; LABA, long-acting β 2 -agonists; LTB4, leukotriene B4; MAPK, mitogenactivated protein kinase; MDI, metered-dose inhaler; NAEPP, National Asthma Education and Prevention Program; OCS, oral corticosteroids; PRN, asneeded; qd, daily

Articles in this issue

Links on this page

view archives of ATS GUIDELINES Bundle - Severe Asthma